Literature DB >> 3704900

Surgical treatment of dermatofibrosarcoma protuberans.

D F Roses, Q Valensi, G LaTrenta, M N Harris.   

Abstract

The clinical course and histopathologic factors of 50 consecutive patients treated for dermatofibrosarcoma protuberans were reviewed. Forty-eight patients were observed until the present time or death. No patient had distant metastases develop, although 16 patients had 18 recurrences of the dermatofibrosarcoma protuberans at the site of initial therapy. There was no correlation between the diameter of the primary lesion and the incidence of recurrence. There was no correlation between the histologic pattern of invasion and recurrence. However, a trend toward decreasing recurrence was noted with increasing minimal margins of resections (41 per cent less than 2 centimeters versus 24 per cent greater than or equal to 2 centimeters). The lowest incidence of recurrence (20 per cent) was noted with minimal margins of resection greater than or equal to 3 centimeters. Five year recurrence free survival rates increased with increasing margins of resection--59 per cent less than 1 centimeter; 66 per cent greater than or equal to 1 centimeter; 70 per cent greater than or equal to 2 centimeters, and 80 per cent greater than or equal to 3 centimeters. No patient had distant metastases and no change in histologic pattern was noted with progressive local recurrence.

Entities:  

Mesh:

Year:  1986        PMID: 3704900

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  15 in total

1.  Treatment of dermatofibrosarcoma protuberans with Mohs micrographic surgery.

Authors:  E R Hobbs; R G Wheeland; P L Bailin; J L Ratz; R J Yetman; J E Zins
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

2.  Dermatofibrosarcoma Protuberans of Lumbar Region with Metastasis to Lung: A Rare Presentation.

Authors:  Anil Khurana; Vijay Kumar J; Paramjeet Kaur; Ashok K Chauhan; Gajender Singh
Journal:  J Clin Diagn Res       Date:  2015-08-01

3.  The ubiquitous fibroblast. Multiple oncogenic potentials with illustrative cases.

Authors:  J D Hardy
Journal:  Ann Surg       Date:  1987-05       Impact factor: 12.969

4.  Dermatofibrosarcoma protuberans of the vulva: a case report.

Authors:  Tufan Oge; Christoph Benedicic; Karl Tamussino; Sigrid Regauer
Journal:  BMJ Case Rep       Date:  2009-03-05

5.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

6.  Incidence and Clinical Features of Rare Cutaneous Malignancies in Olmsted County, Minnesota, 2000 to 2010.

Authors:  Stanislav N Tolkachjov; Adam R Schmitt; John G Muzic; Amy L Weaver; Christian L Baum
Journal:  Dermatol Surg       Date:  2017-01       Impact factor: 3.398

Review 7.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

Review 8.  [Micrographically controlled surgery. Goals and reality].

Authors:  W Weyers
Journal:  Hautarzt       Date:  2007-09       Impact factor: 0.751

9.  Outcome of wide local excision in dermatofibrosarcoma protuberans and use of radiotherapy for margin-positive disease.

Authors:  Raashid Hamid; Adil Hafeez; Mohd A Darzi; Inaam Zaroo; Altaf Rasool; Haroon Rashid
Journal:  Indian Dermatol Online J       Date:  2013-04

10.  Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.

Authors:  Francois G Kamar; Victor F Kairouz; Alain N Sabri
Journal:  Clin Sarcoma Res       Date:  2013-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.